I-Tech AB’s CEO Philip Chaabane will after ten years as the company’s CEO, be proposed as the new Chairman of the Board of I-Tech AB. This...
Developers of Selektope®
I-Tech AB is a public held bio-technology company based in Mölndal, Sweden that owns all IP and regulatory rights to the antifouling agent Selektope® (generic name, medetomidine). I-Tech also controls the largest and most efficient source of medetomidine production.